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Available online 18 February 2016Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of primary effusion lymphoma (PEL), a
rapidly progressing malignancy mostly arising in HIV-infected patients Chen et al. (2007) [1]. Even under con-
ventional chemotherapy, PEL continues to portend nearly 100%mortality within severalmonths, which urgently
requires novel therapeutic strategies. We have previously demonstrated that targeting xCT, an amino acid trans-
porter for cystine/glutamate exchange, induces signiﬁcant PEL cell apoptosis through regulation of multiple host
and viral factors [2]. More importantly, one of xCT selective inhibitors, Sulfasalazine (SASP), effectively prevents
PEL tumor progression in an immune-deﬁcient xenograft model [2]. In the current study, we use Illuminamicro-
array to explore the proﬁle of genes altered by SASP treatment within 3 KSHV+ PEL cell-lines, and discover that
many genes involved in oxidative stress/antioxidant defense system, apoptosis/anti-apoptosis/cell death, and
cellular response to unfolded proteins/topologically incorrect proteins are potentially regulated by xCT Dai
et al. (2015) [3]. Themicroarray original data have been submitted to Gene Expression Omnibus (GEO) database
(Accession number: GSE65418).
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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. This is an open access article under2. Experimental design, materials and methods
2.1. Cell culture and reagents
The PEL cell-line BCBL-1 (KSHV+/EBVneg) was maintained in
RPMI 1640 medium (Gibco) with supplements as described previ-
ously [1,2]. The other PEL cell-lines BC-1 (KSHV+/EBV+) and BCP-1
(KSHV+/EBVneg) were purchased from American Type Culture Col-
lection (ATCC) and maintained in complete RPMI 1640 medium
(ATCC) supplemented with 20% FBS. All cells were cultured at 37 °C
in 5% CO2. All experiments were carried out using cells harvested at
low (b20) passages. Sulfasalazine (SASP) was purchased from Sigma.
2.2. Microarray and data analysis
Microarray analysis was performed and analyzed at the Stanley S.
Scott Cancer Center's Translational Genomics Core at LSUHSC. BC-1,
BCP-1 and BCBL-1 cells were treated with vehicle or the xCT selective
inhibitor SASP (0.5 mM) for 48 h, respectively. Total RNA was isolated
using Qiagen RNeasy kit (Qiagen), and 500 ng of total RNA was used
to synthesize dscDNA. Biotin-labeled RNA was generated using the
TargetAmp-Nano Labeling Kit for Illumina Expression BeadChipthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Intersection analysis of gene proﬁle altered within SASP-treated KSHV+ PEL cell-
lines. The HumanHT-12 v4 Expression BeadChip (Illumina) was used to detect genomic
gene proﬁle altered within 3 SASP-treated KSHV+ PEL cell-lines (BCBL-1, BC-1 and BCP-
1) when compared with vehicle-treated controls. Intersection analysis of signiﬁcantly
altered genes (up/down ≥ 2 folds and p b 0.05) was performed using the Illumina
GenomeStudio Software. Set I: Common genes altered in all the 3 cell-lines; Set II:
Similar genes altered in every 2 cell-lines; Set III: Unique genes altered in each cell-line.
17Z. Qin et al. / Genomics Data 8 (2016) 16–17(Epicenter), according to the manufacturers' instructions, and hybrid-
ized to the HumanHT-12 v4 Expression BeadChip (Illumina) which
containsmore than 47,000probes derived from theNCBI RefSeq Release
38 and other sources, at 58 °C for 16 h. The chip was washed, stained
with streptavadin-Cy3, and scanned with the Illumina BeadStation
500 and BeadScan.
Using the Illumina's GenomeStudio software, we normalized the sig-
nals using the “cubic spline algorithm” that assumes that the distribution
of the transcript abundance is similar in all samples. The backgroundsignal was removed using the “detection p-value algorithm” to remove
targets with signal intensities equal or lower than that of irrelevant
probes (with no known targets in the humangenomebut thermodynam-
ically similar to the relevant probes). The microarray experiments were
performed twice for each group and the average values were used for
analysis. Common, similar, and unique sets of genes and enrichment
analysis were performed using the MetaCore Software (Thompson
Reuters), and the results were summarized in Fig. 1. Enrichment analysis
shows that several major cellular functions were affected within SASP-
treated PEL cells, including oxidative stress/antioxidant defense system,
apoptosis/anti-apoptosis/cell death, and cellular response to unfolded
proteins/topologically incorrect proteins, which is consistent with the
SASP-induced apoptosis phenotype that we recently observed in
KSHV+ PEL cell-lines [2,3]. Therefore, our microarray data indicate that
xCT as well as downstream controlled genes may represent new “drug
targets” for better PEL treatment.
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